•  18
    Diamond and Daniels on Medical Rationing
    Economics and Philosophy 15 (1): 119-125. 1999.
  •  132
    Responsibility and Priority in Liver Transplantation
    Cambridge Quarterly of Healthcare Ethics 18 (1): 23-35. 2009.
    In a provocative 1991 paper, Alvin Moss and Mark Siegler argued that it may be fair to give individuals with alcohol-related end-stage liver disease lower priority for a liver transplant than those who develop end-stage liver disease from other factors. Like other organs, there is a substantial gap between the available livers for transplantation and the number of people who need liver transplants. Yet, unlike those with end-stage renal disease, who can survive for some time on dialysis before r…Read more
  •  56
    Do Genetic Relationships Create Moral Obligations in Organ Transplantation?
    Cambridge Quarterly of Healthcare Ethics 11 (2): 153-159. 2002.
    In 1999, a case was described on national television in which a woman had enlisted onto an international bone marrow registry with the altruistic desire to offer her bone marrow to some unidentified individual in need of a transplant. The potential donor then was notified that she was a compatible match with someone dying from leukemia and gladly donated her marrow, which cured the recipient of the disease. Years later, though, the recipient developed end-stage renal disease, a consequence of th…Read more
  •  57
    In a recent article in this journal, we argued that living organ donation from a parent to a child should be described as a beneficent rather than an altruistic act. Emotional relationships can generate an obligation of beneficence to help those with whom we have these relationships. This may involve an obligation for a parent to donate an organ to a child, even though it entails some risk to the parent. The parent's donation is not altruistic because altruistic acts are not obligatory but optio…Read more
  •  175
    Brain implants, such as Deep Brain Stimulation (DBS), which are designed to improve motor, mood and behavioural pathology, present unique challenges to our understanding of identity, agency and free will. This is because these devices can have visible effects on persons' physical and psychological properties yet are essentially undetectable when operating correctly. They can supplement and compensate for one's inherent abilities and faculties when they are compromised by neuropsychiatric disorde…Read more
  • Daile riviste
    with Michael Ridge, Humean Intentzons, and Moral Responszbzlzty
    Rivista di Filosofia 90 (3). 1999.
  •  9
    What Literary Theory Misses in Wittgenstein
    Philosophy and Literature 10 (2): 263-272. 1986.
    In lieu of an abstract, here is a brief excerpt of the content:Walter Glannon WHAT LITERARY THEORY MISSES IN WITTGENSTEIN Wittgenstein's stock is rising in literary criticism. The market value of expressions such as "language games" and "form oflife" is increasing in that they seem to lend themselves to the notion of interpretive communities endorsed by diose of reader-response persuasion.1 Wittgenstein's style is also apparently at a premium, in light of a recent attempt by a proponent of decon…Read more
  •  9
    Testa and colleagues argue that evaluation for suitability for living donor surgery is rooted in paternalism in contrast with the evaluation for most operative interventions, which is rooted in the autonomy of patients. We examine two key ethical concepts that Testa and colleagues use: paternalism a …
  •  49
    The Value and Disvalue of Consciousness
    Cambridge Quarterly of Healthcare Ethics 25 (4): 600-612. 2016.
  •  26
    Taylor on posthumous organ procurement
    Journal of Medical Ethics 40 (9): 637-638. 2014.
    In defending what he calls ‘full-blooded Epicureanism’, James Stacey Taylor argues that the dead cannot be harmed or wronged.1 This has implications for a range of bioethical issues pertaining to death, including posthumous organ procurement. Taylor claims that respecting the autonomy of persons requires that their desires regarding the treatment of their postmortem bodies be given due consideration while these persons are alive. It is not obvious what this means in practical terms, though Taylo…Read more
  •  27
    The case for libertarian free will
    Inquiry: An Interdisciplinary Journal of Philosophy 42 (2). 1999.
    This Article does not have an abstract
  •  20
    The ethics of human cloning
    Public Affairs Quarterly 12 (3): 287-305. 1998.
  •  51
    The Limitations and Potential of Neuroimaging in the Criminal Law
    The Journal of Ethics 18 (2): 153-170. 2014.
    Neuroimaging showing brain abnormalities is increasingly being introduced in criminal court proceedings to argue that a defendant could not control his behavior and should not be held responsible for it. But imaging has questionable probative value because it does not directly capture brain function or a defendant’s mental states at the time of a criminal act. Advanced techniques could transform imaging from a coarse-grained measure of correlations between brain states and behavior to a fine-gra…Read more
  •  38
    The Moral Insignificance of Death in Organ Donation
    Cambridge Quarterly of Healthcare Ethics 22 (2): 192-202. 2013.
  •  2
    Special Theme for this issue: "Neurodiversity"
    Journal of Ethics in Mental Health 2 1-2. 2007.
  •  75
    Temporal Asymmetry, Life, and Death
    American Philosophical Quarterly 31 (3). 1994.
  •  73
    Semicompatibilism and anomalous monism
    Philosophical Papers 26 (3): 211-231. 1997.
  •  44
    The author's paradox
    British Journal of Aesthetics 28 (3): 239-247. 1988.
  •  29
  • The Blessing and Burden of Biological Psychiatry
    Journal of Ethics in Mental Health 3 1-4. 2008.
    All psychiatric disorders have a neurobiological basis. This has led to a better understanding of these disorders and a reduction in the social stigma associated with them. But the claim that mental states can be explained entirely in neurobiological terms may give us de-stigmatization at the cost of de-personalization. A holistic view of the mind as distributed among the brain, body and environment provides the best model to guide interventions that will have the most salutary ef ects on the br…Read more
  •  17
    Reply to Harris
    Bioethics 16 (3). 2002.
  •  194
    Psychopharmacological enhancement
    Neuroethics 1 (1): 45-54. 2008.
    Many drugs have therapeutic off-label uses for which they were not originally designed. Some drugs designed to treat neuropsychiatric and other disorders may enhance certain normal cognitive and affective functions. Because the long-term effects of cognitive and affective enhancement are not known and may be harmful, a precautionary principle limiting its use seems warranted. As an expression of autonomy, though, competent individuals should be permitted to take cognition- and mood-enhancing age…Read more